PUMA BIOTECHNOLOGY, INC -- SCHEDULE 13G

Company

PUMA BIOTECHNOLOGY, INC.

Filed

February 13, 2017

Accession Number

0001072613-17-000085

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →